Prevention of cisplatin-induced hearing loss in children: achievements and challenges for evidence-based implementation of sodium Thiosulfate
Ototoxicity is a devastating direct, irreversible side effect of platinum use in children with cancer, with its consequent effect on speech, language and social development, quality of life and adult productivity. Cisplatin, an essential chemotherapeutic agent for the treatment of solid tumors in ch...
Main Authors: | Annelot J. M. Meijer, Franciscus A. Diepstraten, Marry M. van den Heuvel-Eibrink, Archie Bleyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1336714/full |
Similar Items
-
A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer
by: Viannique Rolland, et al.
Published: (2019-01-01) -
Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report
by: K. Patel, et al.
Published: (2021-05-01) -
Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin
by: N. Laplace, et al.
Published: (2020-01-01) -
Pancreatitis associated with calciphylaxis successfully treated with sodium thiosulfate
by: Aoibheann Flynn, MD, et al.
Published: (2018-03-01) -
Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae
by: Alonso Anais, et al.
Published: (2022-05-01)